AbbVie Reports Third-Quarter 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
AbbVie (ABBV) Tops Q3 EPS by 7c, Raises FY Guidance
October 30, 2020 7:48 AM EDTAbbVie (NYSE: ABBV) reported Q3 EPS of $2.83, $0.07 better than the analyst estimate of $2.76. Revenue for the quarter came in at $12.9 billion versus the consensus estimate of $12.72 billion.
GUIDANCE:
AbbVie sees FY2020 EPS of $10.47-$10.49, versus the consensus of... More
